Cargando…
Detrimental clinical interaction between ritonavir-boosted protease inhibitors and vinblastin in HIV-infected patients with Hodgkin lymphoma
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The International AIDS Society
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113000/ http://dx.doi.org/10.1186/1758-2652-13-S4-P215 |
| _version_ | 1782205865413050368 |
|---|---|
| author | Cingolani, A Torti, L Pinnetti, C de Gaetano Donati1, K Murri, R Tacconelli, E Larocca, LM Teofili, L |
| author_facet | Cingolani, A Torti, L Pinnetti, C de Gaetano Donati1, K Murri, R Tacconelli, E Larocca, LM Teofili, L |
| author_sort | Cingolani, A |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3113000 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2010 |
| publisher | The International AIDS Society |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-31130002011-06-13 Detrimental clinical interaction between ritonavir-boosted protease inhibitors and vinblastin in HIV-infected patients with Hodgkin lymphoma Cingolani, A Torti, L Pinnetti, C de Gaetano Donati1, K Murri, R Tacconelli, E Larocca, LM Teofili, L J Int AIDS Soc Poster Presentation The International AIDS Society 2010-11-08 /pmc/articles/PMC3113000/ http://dx.doi.org/10.1186/1758-2652-13-S4-P215 Text en Copyright ©2010 Cingolani et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Poster Presentation Cingolani, A Torti, L Pinnetti, C de Gaetano Donati1, K Murri, R Tacconelli, E Larocca, LM Teofili, L Detrimental clinical interaction between ritonavir-boosted protease inhibitors and vinblastin in HIV-infected patients with Hodgkin lymphoma |
| title | Detrimental clinical interaction between ritonavir-boosted protease inhibitors and vinblastin in HIV-infected patients with Hodgkin lymphoma |
| title_full | Detrimental clinical interaction between ritonavir-boosted protease inhibitors and vinblastin in HIV-infected patients with Hodgkin lymphoma |
| title_fullStr | Detrimental clinical interaction between ritonavir-boosted protease inhibitors and vinblastin in HIV-infected patients with Hodgkin lymphoma |
| title_full_unstemmed | Detrimental clinical interaction between ritonavir-boosted protease inhibitors and vinblastin in HIV-infected patients with Hodgkin lymphoma |
| title_short | Detrimental clinical interaction between ritonavir-boosted protease inhibitors and vinblastin in HIV-infected patients with Hodgkin lymphoma |
| title_sort | detrimental clinical interaction between ritonavir-boosted protease inhibitors and vinblastin in hiv-infected patients with hodgkin lymphoma |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113000/ http://dx.doi.org/10.1186/1758-2652-13-S4-P215 |
| work_keys_str_mv | AT cingolania detrimentalclinicalinteractionbetweenritonavirboostedproteaseinhibitorsandvinblastininhivinfectedpatientswithhodgkinlymphoma AT tortil detrimentalclinicalinteractionbetweenritonavirboostedproteaseinhibitorsandvinblastininhivinfectedpatientswithhodgkinlymphoma AT pinnettic detrimentalclinicalinteractionbetweenritonavirboostedproteaseinhibitorsandvinblastininhivinfectedpatientswithhodgkinlymphoma AT degaetanodonati1k detrimentalclinicalinteractionbetweenritonavirboostedproteaseinhibitorsandvinblastininhivinfectedpatientswithhodgkinlymphoma AT murrir detrimentalclinicalinteractionbetweenritonavirboostedproteaseinhibitorsandvinblastininhivinfectedpatientswithhodgkinlymphoma AT tacconellie detrimentalclinicalinteractionbetweenritonavirboostedproteaseinhibitorsandvinblastininhivinfectedpatientswithhodgkinlymphoma AT laroccalm detrimentalclinicalinteractionbetweenritonavirboostedproteaseinhibitorsandvinblastininhivinfectedpatientswithhodgkinlymphoma AT teofilil detrimentalclinicalinteractionbetweenritonavirboostedproteaseinhibitorsandvinblastininhivinfectedpatientswithhodgkinlymphoma |